title: Opiate receptor avidity in the thalamus is sexually dimorphic in the elderly.
abstract: Opiate receptor avidity (B(')(max)/K(D)), was measured in the subcortex of nine females (five healthy subjects, four Alzheimer patients) and 15 males (seven healthy subjects, eight Alzheimer patients), 51-75 years of age, with the opiate receptor antagonist 6-deoxy-6-beta-[(18)F]fluoronaltrexone (cyclofoxy, CF) and a positron emission tomograph. CF avidity was 27.5% less in the thalamus of healthy women compared to healthy men and 48.5% less in Alzheimer disease female patients compared to male patients.
authors.affiliation: Laboratory of Cerebral Metabolism, National Institute of Mental Health, Bethesda, Maryland 20982-1274, USA. bob@shiloh.nimh.nih.gov
authors.forename: R M
authors.initials: RM
authors.lastname: Cohen
authors.forename: R E
authors.initials: RE
authors.lastname: Carson
authors.forename: T
authors.initials: T
authors.lastname: Sunderland
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000000981:diagnostic imaging / Q000378:metabolism*; D000704:Analysis of Variance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009271:Naltrexone / Q000031:analogs & derivatives* / Q000378:metabolism; D011957:Receptors, Opioid / Q000378:metabolism*; D012044:Regression Analysis; D012737:Sex Factors; D013788:Thalamus / Q000000981:diagnostic imaging / Q000378:metabolism*; D014055:Tomography, Emission-Computed
chemical_list: D011957:Receptors, Opioid; D009271:Naltrexone; C066758:6-deoxy-6-fluoronaltrexone